When you develop and produce active pharma ingredients (API’s), there are always some impurities – identifying the chemical structure of the known ones is usually not a problem, but what about the unknown?

Whether the impurities are process-related or coming from the degradation of products they always need to be identified and classified accordingly.

With some of the best chemists in the industry using state of the art science and lab techniques, it now really is possible to identify the unidentified!

At QUINTA-ANALYTICA we offer structure elucidation, characterization, and full certification in both Research and Development (R&D) or Good Manufacturing Practice (GMP) mode. Our specialist labs are even able to do isotopically labeled compound enrichment.

With a global approach to business and multiple labs within central Europe, Quinta-Analytica is your true pharma partner.

Contact us today to learn more about the catalog of services we offer.

Additional News

  • 20 November 2025

    Webinar: Streamlined Evidence Strategies for Biosimilars: Analytics, PK and Immunogenicity in focus

    On behalf of Conscio Group, we are pleased to invite you to the upcoming free educational webinar from biosimilar series.

  • 11 September 2025

    Meet us at CPHI 2025

    This October, the global pharmaceutical community will gather in Frankfurt for CPHI 2025. Quinta-Analytica as a member of Conscio Group will be there too – visit us in the Contract Manufacturing Hall 5.1, Stand F1.

  • 8 September 2025

    Quinta-Analytica successfully passed two onsite FDA inspections

    In the first half of 2025, Quinta-Analytica underwent two onsite inspections by the U.S. Food and Drug Administration (FDA).